Large amounts of data ("big data") offer enormous potential for improving the accuracy of genome-wide predictions in plant ...

Company further extends cash guidance into 2028 Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) thera ...